Search

Your search keyword '"Berenger M"' showing total 18 results
Start Over Author "Berenger M"
18 results on '"Berenger M"'

1. Meeting Report: ESC Forum on Drug Eluting Stents European Heart House, Nice, 27–28 September 2007

Author

Daemen, Joost, Simoons, Maarten L., Wijns, William, Bagust, Adrian, Bos, Gert, Bowen, James M., Braunwald, Eugene, Camenzind, Edoardo, Chevalier, Bernard, DiMario, Carlo, Fajadet, Jean, Gitt, Anselm, Guagliumi, Giulio, Hillege, Hans L., James, Stefan, Jüni, Peter, Kastrati, Adnan, Kloth, Sabine, Kristensen, Steen D., Krucoff, Mitchell, Legrand, Victor, Pfisterer, Matthias, Rothman, Martin, Serruys, Patrick W., Silber, Sigmund, Steg, Philippe G., Tariah, Ibrahim, Wallentin, Lars, Windecker, Stephan W., Aimonetti, A., Allocco, D., Baczynska, A., Bagust, A., Berenger, M., Bos, G., Boam, A., Bowen, J.M., Braunwald, E., Calle, J.P., Camenzind, E., Campo, G., Carlier, S., Chevalier, B., Daemen, J., de Schepper, J., Di Bisceglie, G., DiMario, C., Dobbels, H., Fajadet, J., Farb, A., Ghislain, J.C., Gitt, A., Guagliumi, G., Hellbardt, S., Hillege, H.L., ten Hoedt, R., Isaia, C., James, S., de Jong, P., Jüni, P., Kastrati, A., Klasen, E., Kloth, S., Kristensen, S.D., Krucoff, M., Legrand, V., Lekehal, M., LeNarz, L., Ni Mhullain, F., Nagai, H., Patteet, A., Paunovic, D., Pfisterer, M., Potgieter, A., Purdy, I., Raveau-Landon, C., Rothman, M., Serruys, P.W., Silber, S., Simoons, M.L., Steg, P.G., Tariah, I., Ternstrom, S., Van Wuytswinkel, J., Waliszewski, M., Wallentin, L., Wijns, W., and Windecker, S.W.

Published
2009

2. Difficult-to-treat axial spondyloarthritis is associated with psoriasis, peripheral involvement and comorbidities: results of an observational nationwide study

Author

Daniel Wendling, Clément Prati, Olivier Fakih, Frank Verhoeven, Maxime Desmarets, Bérenger Martin, and Elisabeth Monnet

Subjects
Medicine
Abstract

Objectives To determine the cumulative incidence and identify the factors associated with difficult-to-treat axial spondyloarthritis (D2T-axSpA) in French patients newly benefiting from the French ‘long-term illness’ (LTI) social security scheme for axial spondyloarthritis (axSpA).Methods This national cohort study was based on the French National Medico-Administrative Database, SNDS, which contains data on hospitalisation, LTI and outpatient care consumption. All French patients newly receiving LTI benefits for ankylosing spondylitis (AS) between 2010 and 2013 were included in the study. In France, LTI is required to access biological/targeted synthetic DMARDs (b/tsDMARDs). The follow-up period ended on 31 December 2018. So-called D2T-axSpA was defined as the failure of three b/tsDMARDs or of two b/tsDMARDs with different modes of action. Comorbidities and extra-musculoskeletal manifestations were identified using previously described algorithms. Characteristics were compared between patients with D2T-axSpA and patients with non-D2T-axSpA who had received at least one b/tsDMARD with bivariate and multivariate analysis using logistic regression. Incidence rates of major cardiovascular event (MACE) and death were compared using competitive risk analysis.Results 22 932 patients were included. 10 798 (47.08%) patients received at least one bDMARD. None received tsDMARD. During follow-up, 2115 patients were classified as having D2T-axSpA, representing 19.59% of patients who received at least one bDMARD. In multivariate analysis, D2T-axSpA was significantly associated with female gender, peripheral involvement, psoriasis, hypertension and depression (p

Published
2023
Full Text
View/download PDF

3. Meeting Report: ESC Forum on Drug Eluting Stents European Heart House, Nice, 27-28 September 2007

Author

Daemen, Joost, Simoons, Maarten L., Wijns, William, Bagust, Adrian, Bos, Gert, Bowen, James M., Braunwald, Eugene, Camenzind, Edoardo, Chevalier, Bernard, DiMario, Carlo, Fajadet, Jean, Gitt, Anselm, Guagliumi, Giulio, Hillege, Hans L., James, Stefan, Jüni, Peter, Kastrati, Adnan, Kloth, Sabine, Kristensen, Steen D., Krucoff, Mitchell, Legrand, Victor, Pfisterer, Matthias, Rothman, Martin, Serruys, Patrick W., Silber, Sigmund, Steg, Philippe G., Tariah, Ibrahim, Wallentin, Lars, Windecker, Stephan W., Aimonetti, A., Allocco, D., Baczynska, A., Bagust, A., Berenger, M., Bos, G., Boam, A., Bowen, J.M., Braunwald, E., Calle, J.P., Camenzind, E., Campo, G., Carlier, S., Chevalier, B., Daemen, J., de Schepper, J., Di Bisceglie, G., DiMario, C., Dobbels, H., Fajadet, J., Farb, A., Ghislain, J.C., Gitt, A., Guagliumi, G., Hellbardt, S., Hillege, H.L., ten Hoedt, R., Isaia, C., James, S., de Jong, P., Jüni, P., Kastrati, A., Klasen, E., Kloth, S., Kristensen, S.D., Krucoff, M., Legrand, V., Lekehal, M., LeNarz, L., Ni Mhullain, F., Nagai, H., Patteet, A., Paunovic, D., Pfisterer, M., Potgieter, A., Purdy, I., Raveau-Landon, C., Rothman, M., Serruys, P.W., Silber, S., Simoons, M.L., Steg, P.G., Tariah, I., Ternstrom, S., Van Wuytswinkel, J., Waliszewski, M., Wallentin, L., Wijns, W., Windecker, S.W., Daemen, Joost, Simoons, Maarten L., Wijns, William, Bagust, Adrian, Bos, Gert, Bowen, James M., Braunwald, Eugene, Camenzind, Edoardo, Chevalier, Bernard, DiMario, Carlo, Fajadet, Jean, Gitt, Anselm, Guagliumi, Giulio, Hillege, Hans L., James, Stefan, Jüni, Peter, Kastrati, Adnan, Kloth, Sabine, Kristensen, Steen D., Krucoff, Mitchell, Legrand, Victor, Pfisterer, Matthias, Rothman, Martin, Serruys, Patrick W., Silber, Sigmund, Steg, Philippe G., Tariah, Ibrahim, Wallentin, Lars, Windecker, Stephan W., Aimonetti, A., Allocco, D., Baczynska, A., Bagust, A., Berenger, M., Bos, G., Boam, A., Bowen, J.M., Braunwald, E., Calle, J.P., Camenzind, E., Campo, G., Carlier, S., Chevalier, B., Daemen, J., de Schepper, J., Di Bisceglie, G., DiMario, C., Dobbels, H., Fajadet, J., Farb, A., Ghislain, J.C., Gitt, A., Guagliumi, G., Hellbardt, S., Hillege, H.L., ten Hoedt, R., Isaia, C., James, S., de Jong, P., Jüni, P., Kastrati, A., Klasen, E., Kloth, S., Kristensen, S.D., Krucoff, M., Legrand, V., Lekehal, M., LeNarz, L., Ni Mhullain, F., Nagai, H., Patteet, A., Paunovic, D., Pfisterer, M., Potgieter, A., Purdy, I., Raveau-Landon, C., Rothman, M., Serruys, P.W., Silber, S., Simoons, M.L., Steg, P.G., Tariah, I., Ternstrom, S., Van Wuytswinkel, J., Waliszewski, M., Wallentin, L., Wijns, W., and Windecker, S.W.

Published
2017

4. Influence des conditions et matériels de pulvérisation sur les pertes de pesticides au sol et dans l'air en viticulture Languedocienne

Author

Sinfort, C., Cotteux, E., Bonicelli, B., Ruelle, B., Douchin, M., Berenger, M., Lagrevol, J., Liet, O., De Rudnicki, V., Information – Technologies – Analyse Environnementale – Procédés Agricoles (UMR ITAP), and Centre international d'études supérieures en sciences agronomiques (Montpellier SupAgro)-Centre national du machinisme agricole, du génie rural, des eaux et forêts (CEMAGREF)

Subjects
PRODUIT PHYTOSANITAIRE, PULVERISATEUR, [SDE]Environmental Sciences, POLLUTION DE L'AIR, POLLUTION DU SOL
Abstract

National audience; Les traitements phytosanitaires des vignes entraînent des pertes vers l'environnement (sol, air) qui sont la cause de pollutions diffuses. Trois campagnes d'essais (une par an) ont été mises en place pour : quantifier les pertes de pesticide, comparer les effets des technologies des pulvérisateurs et évaluer l'importance des réglages des machines. Une méthodologie a été développée pour évaluer les pertes de pesticides. Elle est basée sur l'utilisation d'un traceur fluorescent (de la Brillant Sulfo Flavine) piégé sur des collecteurs adaptés à chaque compartiment évalué (sol, plante, air). Les quantités de dépôt sont ensuite obtenues par une analyse spectro-fluorimétrique. L'efficience des collecteurs a été préalablement testée en laboratoire. Le positionnement des collecteurs à l'intérieur des parcelles d'essai ont également été optimisées pour assurer une bonne estimation des dépôts réels. Les résultats montrent que le protocole de mesure donne une bonne estimation du devenir des pesticides puisque environ 100% du produit pulvérisé est retrouvé à partir des collecteurs dans les différents compartiments. Les quantités de produit perdu sont considérables : entre 10 et 45% sur le sol et entre 15 et 40% dans l'air.

Published
2009

5. ESC Forum on Drug Eluting Stents European Heart House, Nice, 27-28 September 2007

Author

Daemen, Joost, Simoons, Maarten L, Wijns, William, Bagust, Adrian, Bos, Gert, Bowen, James M, Braunwald, Eugene, Camenzind, Edoardo, Chevalier, Bernard, Dimario, Carlo, Fajadet, Jean, Gitt, Anselm, Guagliumi, Giulio, Hillege, Hans L, James, Stefan, Jüni, Peter, Kastrati, Adnan, Kloth, Sabine, Kristensen, Steen D, Krucoff, Mitchell, Legrand, Victor, Pfisterer, Matthias, Rothman, Martin, Serruys, Patrick W, Silber, Sigmund, Steg, Philippe G, Tariah, Ibrahim, Wallentin, Lars, Windecker, Stephan W, Aimonetti, A, Allocco, D, Baczynska, A, Bagust, A, Berenger, M, Bos, G, Boam, A, Bowen, J M, Braunwald, E, Calle, J P, Camenzind, E, Campo, G, Carlier, S, Chevalier, B, Daemen, J, de Schepper, J, Di Bisceglie, G, Dimario, C, Dobbels, H, Fajadet, J, Farb, A, Ghislain, J C, Gitt, A, Guagliumi, G, Hellbardt, S, Hillege, H L, Ten Hoedt, R, Isaia, C, James, S, de Jong, P, Jüni, P, Kastrati, A, Klasen, E, Kloth, S, Kristensen, S D, Krucoff, M, Legrand, V, Lekehal, M, Lenarz, L, Ni Mhullain, F, Nagai, H, Patteet, A, Paunovic, D, Pfisterer, M, Potgieter, A, Purdy, I, Raveau-Landon, C, Rothman, M, Serruys, P W, Silber, S, Simoons, M L, Steg, P G, Tariah, I, Ternstrom, S, Van Wuytswinkel, J, Waliszewski, M, Wallentin, L, Wijns, W, and Windecker, S W

Abstract

Udgivelsesdato: 2009-Jan

Published
2009
Full Text
View/download PDF

6. Outdoor sound propagation modelling in complex environments : a new PE code coupled with a micrometeorological code

Author

Lihoreau, Bertrand, Gauvreau, B., PENELON, T., Calmet, I., Berenger, M., Blanc-Benon, Ph., Laboratoire de recherche en Hydrodynamique, Énergétique et Environnement Atmosphérique (LHEEA), and École Centrale de Nantes (ECN)-Centre National de la Recherche Scientifique (CNRS)

Subjects
[PHYS.MECA.MEFL]Physics [physics]/Mechanics [physics]/Fluid mechanics [physics.class-ph], ComputingMilieux_MISCELLANEOUS
Abstract

International audience

Published
2004

7. Does air pollution really impact the onset of spontaneous pneumothorax? A French case-crossover study

Author

Tania Marx, Nadine Bernard, Anne-Laure Parmentier, Marc Puyraveau, Berenger Martin, Madeleine Gantelet, Jean-Baptiste Pretalli, Jean-Charles Dalphin, Frédéric Mauny, and Thibaut Desmettre

Subjects
Environmental sciences, GE1-350
Abstract

Rationale: A link is established between air pollution and respiratory diseases. Very few studies evaluated this link with primary spontaneous pneumothorax (PSP). Contrasted results, low statistical power and methodological limits of these studies brought us to evaluate in a more thorough way this link. Objectives: (1) to estimate the relation between PSP and air pollutants namely nitrogen dioxide (NO2), ozone (O3) and particulate matter with a diameter ≤ 10 μm (PM10); (2) to investigate a time lag effect between these pollutants and occurrence of PSP. Methods: This study has a case-crossover design. Subjects aged ≥18 years admitted from 1st June 2009 to 31st May 2013, in 14 Emergency Departments centers on the French territory. Were excluded: patients with traumatic, secondary, recurrent or history of previous pneumothorax. NO2, O3 and PM10 data were collected hourly in monitoring stations. Three exposure assessments were retained: quantitative values, fast increase concentration of air pollutants and peak of pollution. These assessments were calculated for the entire exposure period and for each of the four days of all case and control periods. Results: 948 subjects included. Whatever the pollutant considered, no differences were observed between case and control periods, regardless of whether the quantitative values of air pollutants exposure (p > 0.09), fast increase concentration (p > 0.46) and peak of pollution (p > 0.20). Conclusions: We failed to show a relation between PSP and short-term air pollution exposure to low levels of NO2 and PM10. An association between O3 exposure and PSP cannot be ruled out. An impact at higher exposure level, and/or a potentiating effect of different meteorological factors remain to be demonstrated. Keywords: Pneumothorax, Air pollution, Case-crossover study

Published
2019
Full Text
View/download PDF

10. Meeting Report: ESC Forum on Drug Eluting Stents European Heart House, Nice, 27-28 September 2007

Author

Daemen, Joost, Simoons, Maarten L., Wijns, William, Bagust, Adrian, Bos, Gert, Bowen, James M., Braunwald, Eugene, Camenzind, Edoardo, Chevalier, Bernard, DiMario, Carlo, Fajadet, Jean, Gitt, Anselm, Guagliumi, Giulio, Hillege, Hans L., James, Stefan, Jüni, Peter, Kastrati, Adnan, Kloth, Sabine, Kristensen, Steen D., Krucoff, Mitchell, Legrand, Victor, Pfisterer, Matthias, Rothman, Martin, Serruys, Patrick W., Silber, Sigmund, Steg, Philippe G., Tariah, Ibrahim, Wallentin, Lars, Windecker, Stephan W., Aimonetti, A., Allocco, D., Baczynska, A., Bagust, A., Berenger, M., Bos, G., Boam, A., Bowen, J.M., Braunwald, E., Calle, J.P., Camenzind, E., Campo, G., Carlier, S., Chevalier, B., Daemen, J., de Schepper, J., Di Bisceglie, G., DiMario, C., Dobbels, H., Fajadet, J., Farb, A., Ghislain, J.C., Gitt, A., Guagliumi, G., Hellbardt, S., Hillege, H.L., ten Hoedt, R., Isaia, C., James, S., de Jong, P., Jüni, P., Kastrati, A., Klasen, E., Kloth, S., Kristensen, S.D., Krucoff, M., Legrand, V., Lekehal, M., LeNarz, L., Ni Mhullain, F., Nagai, H., Patteet, A., Paunovic, D., Pfisterer, M., Potgieter, A., Purdy, I., Raveau-Landon, C., Rothman, M., Serruys, P.W., Silber, S., Simoons, M.L., Steg, P.G., Tariah, I., Ternstrom, S., Van Wuytswinkel, J., Waliszewski, M., Wallentin, L., Wijns, W., Windecker, S.W., Daemen, Joost, Simoons, Maarten L., Wijns, William, Bagust, Adrian, Bos, Gert, Bowen, James M., Braunwald, Eugene, Camenzind, Edoardo, Chevalier, Bernard, DiMario, Carlo, Fajadet, Jean, Gitt, Anselm, Guagliumi, Giulio, Hillege, Hans L., James, Stefan, Jüni, Peter, Kastrati, Adnan, Kloth, Sabine, Kristensen, Steen D., Krucoff, Mitchell, Legrand, Victor, Pfisterer, Matthias, Rothman, Martin, Serruys, Patrick W., Silber, Sigmund, Steg, Philippe G., Tariah, Ibrahim, Wallentin, Lars, Windecker, Stephan W., Aimonetti, A., Allocco, D., Baczynska, A., Bagust, A., Berenger, M., Bos, G., Boam, A., Bowen, J.M., Braunwald, E., Calle, J.P., Camenzind, E., Campo, G., Carlier, S., Chevalier, B., Daemen, J., de Schepper, J., Di Bisceglie, G., DiMario, C., Dobbels, H., Fajadet, J., Farb, A., Ghislain, J.C., Gitt, A., Guagliumi, G., Hellbardt, S., Hillege, H.L., ten Hoedt, R., Isaia, C., James, S., de Jong, P., Jüni, P., Kastrati, A., Klasen, E., Kloth, S., Kristensen, S.D., Krucoff, M., Legrand, V., Lekehal, M., LeNarz, L., Ni Mhullain, F., Nagai, H., Patteet, A., Paunovic, D., Pfisterer, M., Potgieter, A., Purdy, I., Raveau-Landon, C., Rothman, M., Serruys, P.W., Silber, S., Simoons, M.L., Steg, P.G., Tariah, I., Ternstrom, S., Van Wuytswinkel, J., Waliszewski, M., Wallentin, L., Wijns, W., and Windecker, S.W.

12. New koala chlamydia vaccine trialed.

Author

Berenger M

Subjects
Animals, Chlamydia Infections prevention & control, Bacterial Vaccines, Chlamydia immunology, Chlamydia Infections veterinary, Phascolarctidae
Published
2016

14. Rabies is a real risk in Australia.

Author

Berenger M

Subjects
Animals, Australia, Bites and Stings therapy, Bites and Stings veterinary, Bites and Stings virology, Dogs, Humans, Public Health Practice, Rabies transmission, Rabies Vaccines therapeutic use, Zoonoses prevention & control, Zoonoses transmission, Communicable Disease Control methods, Rabies prevention & control
Published
2014

17. ESC Forum on Drug Eluting Stents European Heart House, Nice, 27-28 September 2007.

Author

Daemen J, Simoons ML, Wijns W, Bagust A, Bos G, Bowen JM, Braunwald E, Camenzind E, Chevalier B, Dimario C, Fajadet J, Gitt A, Guagliumi G, Hillege HL, James S, Jüni P, Kastrati A, Kloth S, Kristensen SD, Krucoff M, Legrand V, Pfisterer M, Rothman M, Serruys PW, Silber S, Steg PG, Tariah I, Wallentin L, Windecker SW, Aimonetti A, Allocco D, Baczynska A, Bagust A, Berenger M, Bos G, Boam A, Bowen JM, Braunwald E, Calle JP, Camenzind E, Campo G, Carlier S, Chevalier B, Daemen J, de Schepper J, Di Bisceglie G, Dimario C, Dobbels H, Fajadet J, Farb A, Ghislain JC, Gitt A, Guagliumi G, Hellbardt S, Hillege HL, Ten Hoedt R, Isaia C, James S, de Jong P, Jüni P, Kastrati A, Klasen E, Kloth S, Kristensen SD, Krucoff M, Legrand V, Lekehal M, Lenarz L, Ni Mhullain F, Nagai H, Patteet A, Paunovic D, Pfisterer M, Potgieter A, Purdy I, Raveau-Landon C, Rothman M, Serruys PW, Silber S, Simoons ML, Steg PG, Tariah I, Ternstrom S, Van Wuytswinkel J, Waliszewski M, Wallentin L, Wijns W, and Windecker SW

Subjects
Coronary Disease mortality, Coronary Disease therapy, Coronary Restenosis prevention & control, Coronary Thrombosis etiology, Coronary Thrombosis mortality, Epidemiologic Methods, France, Humans, Myocardial Infarction mortality, Myocardial Revascularization adverse effects, Myocardial Revascularization standards, Drug-Eluting Stents adverse effects, Drug-Eluting Stents economics, Drug-Eluting Stents standards
Published
2009
Full Text
View/download PDF

18. Meeting report ESC forum on drug eluting stents, European Heart House, Nice, 27-28 September 2007.

Author

Daemen J, Simoons ML, Wijns W, Bagust A, Bos G, Bowen JM, Braunwald E, Camenzind E, Chevaliers B, DiMario C, Fajadeto J, Gitt A, Guagliumi G, Hillege HL, James S, Jüni P, Kastrati A, Kloth S, Kristensen SD, Krucoff M, Legrand V, Pfisterer M, Rothman M, Serruys PW, Silber S, Steg PG, Tariah I, Wallentin L, Windecker SW, Aimonetti A, Allocco D, Berenger M, Boam A, Calle JP, Campo G, Carlier S, de Schepper J, Di Bisceglie G, Dobbels H, Farb A, Ghislain JC, Hellbardt S, ten Hoedt R, Isaia C, de Jong P, Lekehal M, LeNarz L, Mhullain FN, Nagai H, Patteet A, Paunovic D, Potgieter A, Purdy I, Raveau-Landon C, Ternstrom S, Van Wuytswinkel J, and Waliszewski M

Subjects
Angioplasty, Balloon, Coronary adverse effects, Angioplasty, Balloon, Coronary economics, Cardiovascular Agents economics, Cardiovascular Diseases etiology, Clinical Trials as Topic, Coronary Artery Disease economics, Cost-Benefit Analysis, Health Care Costs, Humans, Platelet Aggregation Inhibitors therapeutic use, Prosthesis Design, Registries, Treatment Outcome, Angioplasty, Balloon, Coronary instrumentation, Cardiovascular Agents administration & dosage, Coronary Artery Disease therapy, Drug-Eluting Stents economics, Metals, Stents economics
Published
2009

Catalog

Books, media, physical & digital resources
See catalog results